Document:AXA/2025/FY/Earnings presentation (press): Difference between revisions

Content deleted Content added
doc_archive: pair p1abw4 (figure identity) (.md link)
doc_archive: pair p1abw4 (figure identity) (.md link)
 
(9 intermediate revisions by the same user not shown)
Line 53:
* {{t|2|p1abw4-9tbw}} Business Performance
* Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk and Technology
* {{t|3|}} Financial Performance
* Alban de Mailly Nesle, Group CFO
* {{t|4|p1abw4-vacu}} France
Line 70:
 
* REVENUES
* {{t|€116€116bn|p1abw4-yxjw}}bn
* {{t|+6%|p1abw4-yutx}} vs {{t|FY24|p1abw4-ndok}}
* UNDERLYING EARNINGS
* {{t|€8.44bn|p1abw4-oasi}}bn
* {{t|+6%|p1abw4-xtf8}} vs {{t|FY24|p1abw4-3bra}}
* {{t|+9%|p1abw4-z72l}} Excl. {{t|AXA IM|p1abw4-9cne}}
* {{t|UEPS|p1abw4-5ldr}}
* {{t|€3.86|p1abw4-l996}}
* {{t|+8%|p1abw4-dpes}} vs {{t|FY24|p1abw4-ul38}}
* {{t|DIVIDEND|p1abw4-d0x9}}{{fn ref|1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}}
* {{t|€2.32|p1abw4-1cs9}}
* {{t|+8%|p1abw4-idom}} vs {{t|FY24|p1abw4-eqyj}}
* SOLVENCY II RATIO
* {{t|224%|p1abw4-ts7x}}
* {{t|+9pts|p1abw4-t41o}} {{t|FY25|p1abw4-f4de}}
 
<div class="ed-fn-notes" style="display:none">
Line 103:
|-
| style="text-align:left" | {{t|P&amp;C|p1abw4-b57v}}
| style="text-align:left" | {{t|€58.0bn|p1abw4-jqov}} <br/> {{t|+5%|p1abw4-pawh}} vs FY24
| style="text-align:right" | {{t|€5.9bn|p1abw4-1m4z}} <br/> {{t|+9%|p1abw4-0iy6}} vs FY24
| style="text-align:right" | {{t|90.6%|p1abw4-v9el}} <br/> vs {{t|91.0%|p1abw4-dwya}} FY24
|-
| style="text-align:left" | LIFE
| style="text-align:left" | {{t|€37.5bn|p1abw4-qrrm}} <br/> {{t|+9%|p1abw4-0iy6}} vs FY24
| style="text-align:right" | {{t|€2.7bn|p1abw4-j8uf}} <br/> {{t|+4%|p1abw4-z85f}} vs FY24
| style="text-align:right" | —
|-
| style="text-align:left" | HEALTH
| style="text-align:left" | {{t|€19.0bn|p1abw4-okof}} <br/> {{t|+5%|p1abw4-bxk2}} vs FY24
| style="text-align:right" | {{t|€0.8bn|p1abw4-xr40}} <br/> {{t|+17%|p1abw4-4l05}} vs FY24
| style="text-align:right" | {{t|97.9%|p1abw4-w1gu}} <br/> vs {{t|98.1%|p1abw4-mae8}} FY24
|}
</div>
Line 170:
'''ARTIFICIAL INTELLIGENCE'''
* AI is a strategic technology, bringing major benefits to businesses
* Beyond increased efficiency, AI will transform access to insurance, product personalization, and the customer experience; {{t|AXA|p1abw4-scha}} wants to be firmly positioned in this evolution
* AI is already concretely improving pricing accuracy, underwriting quality, and claims management
 
Line 181:
 
'''Customers'''
* More than {{t|€49€49bn|p1abw4-sp63}}bn in claims paid
* {{t|€438€438m|p1abw4-a069}}m climate related claims in France
 
'''Economy'''
* More than {{t|€40€40bn|p1abw4-astb}}bn invested in the economy
* {{t|€12.88bn|p1abw4-mdil}}bn{{fn ref|1|2=€12.8bn of tax and social contributions paid}} of tax and social contributions paid, of which {{t|36.7%|p1abw4-zfkw}} in France
* Launch of {{t|AXA|p1abw4-x72v}} Foundation for Human Progress with {{t|€60m/year|p1abw4-6jwz}} endowed by {{t|AXA|p1abw4-dirj}} Mutuelles d’Assurances and {{t|AXA Group|p1abw4-klo5}}
 
'''Employees'''
* {{t|€7€7bn|p1abw4-n0oi}}bn total compensation paid to our employees
* {{t|15,115|p1abw4-7vdu}} recruitments worldwide (*excl. short-term contracts and trainees*) including {{t|2,138|p1abw4-f1b9}} in France
* More than {{t|36%|p1abw4-wgww}} of employees are {{t|AXA|p1abw4-pt7c}} shareholders and hold {{t|4.82%|p1abw4-gq00}} of the capital and {{t|6.61%|p1abw4-q60s}} of its voting rights
 
'''Climate transition'''
* {{t|€4.66bn|p1abw4-7z3z}}bn in premiums related to transition with a target of {{t|€6€6bn|p1abw4-uur8}}bn cumulated between {{t|2024|p1abw4-5fmw}} and {{t|2026|p1abw4-723n}}{{fn ref|2|2=target of €6bn cumulated between 2024 and 2026}}
* {{t|€6.44bn|p1abw4-2akx}}bn in investments to accelerate climate transition with a target of {{t|€5€5bn|p1abw4-pu7f}}bn annually{{fn ref|3|2=target of €5bn annually}}
 
<div class="ed-fn-notes" style="display:none">
Line 236:
|-
| style="text-align:left" | France<br/>(27% of total {{t|GWP|p1abw4-o4wo}}{{fn ref|1}})
| style="text-align:right" | {{t|€31bn|p1abw4-y899}}<br/>{{t|+6%|p1abw4-luln}}
| style="text-align:right" | {{t|€2.2bn|p1abw4-xvcn}}<br/>{{t|+7%|p1abw4-g633}}
|-
| style="text-align:left" | Europe<br/>(38% of total {{t|GWP|p1abw4-o4wo}}{{fn ref|1}})
| style="text-align:right" | {{t|€43bn|p1abw4-79dl}}<br/>{{t|+6%|p1abw4-luln}}
| style="text-align:right" | {{t|€3.5bn|p1abw4-efpj}}<br/>{{t|+9%|p1abw4-bwba}}
|-
| style="text-align:left" | {{t|AXA XL|p1abw4-z73y}}<br/>(17% of total {{t|GWP|p1abw4-o4wo}}{{fn ref|1}})
| style="text-align:right" | {{t|€19bn|p1abw4-kuuu}}<br/>{{t|+4%|p1abw4-7lte}}
| style="text-align:right" | {{t|€1.9bn|p1abw4-qdgj}}<br/>{{t|+9%|p1abw4-jxem}}
|-
| style="text-align:left" | Asia, Africa &amp; EME-LATAM<br/>(18% of total {{t|GWP|p1abw4-o4wo}}{{fn ref|1}})
| style="text-align:right" | {{t|€20bn|p1abw4-2prq}}<br/>{{t|+13%|p1abw4-xzp6}}
| style="text-align:right" | {{t|€1.5bn|p1abw4-2vf0}}<br/>{{t|+6%|p1abw4-luln}}
|}
</div>
Line 258:
=== P&C – Strong margins, confidence in sustaining growth ===
 
* {{t|€58€58bn|p1abw4-2b31}}bn {{t|GWP|p1abw4-07ne}}
* Retail
* SME & Mid-market
* {{t|AXA XL|p1abw4-6wor}}{{fn ref|2|2=AXA XL includes AXA XL Insurance and AXA XL Reinsurance}} (Large & Specialty)
* {{t|UNDERLYING EARNINGS|p1abw4-un4a}} {{t|+9%|p1abw4-exy4}}{{fn ref|1|2=Underlying earnings growth}} to {{t|€5.99bn|p1abw4-j3vo}}bn
 
<div style="overflow-x:auto">
Line 276:
| style="text-align:left" | Investing to improve customer retention &amp; expanding distribution footprint
|-
| style="text-align:left" | {{t|AXA XL|p1abw4-18nd}} (Large &amp; Specialty)
| style="text-align:left" | Profitable growth with stable margins
| style="text-align:left" | Capitalizing on attractive growth opportunities and continued cycle management
Line 290:
=== Life & Health – Good momentum, well positioned to capture growth opportunities ===
 
* {{t|€57€57bn|p1abw4-3iqs}}bn {{t|GWP|p1abw4-971o}}
* {{t|GWP|p1abw4-971o}} mix: Health, Protection, G/A Savings — shares not printed
* UNDERLYING EARNINGS {{t|+7%|p1abw4-ld81}}{{fn ref|1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}} to {{t|€3.55bn|p1abw4-x68g}}bn
 
'''Health'''
* {{t|2025|}}: Competitive advantages with innovative products integrating more prevention
* BEYOND {{t|2025|}}: Capitalizing on demand for health & protection while further improving our margins
 
'''Protection'''
* {{t|2025|}}: Continued strong commercial momentum, especially in Japan and Switzerland
* BEYOND {{t|2025|}}: Capitalizing on demand for health & protection while further improving our margins
 
'''G/A Savings'''
* {{t|2025|}}: Accelerating net flows in Savings at attractive margins
* BEYOND {{t|2025|}}: Capturing savings & retirement opportunity, sourcing best asset management products for our customers
 
<div class="ed-fn-notes" style="display:none">
Line 375:
 
'''Retail lines'''
* Favorable pricing trends and strong growth in net new contracts ({{t|+1.77m|p1abw4-vvry}}m in {{t|FY25|p1abw4-h7vb}})
 
<div class="ed-fn-notes" style="display:none">
Line 431:
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY24|p1abw4-votc}}
! class="col-s" style="text-align:right" | {{t|FY25|}}
! class="col-s" style="text-align:right" | Change
|-
Line 469:
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY24|}}
! class="col-s" style="text-align:right" | {{t|FY25|}}
! class="col-s" style="text-align:right" | Change
|-
Line 495:
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY25|}}
|-
| style="text-align:left" | Protection
Line 517:
</div>
 
* Net Flows vs {{t|FY24|}}
* {{t|€+5.44bn|p1abw4-cocg}}bn vs {{t|€+1.55bn|p1abw4-sgh7}}bn in {{t|FY24|p1abw4-votc}}
 
{{pdf page|20|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aaAYJ8FoBIGEg2j6_AXA_Full_Year_Results_2025_Press.pdf}}
Line 817:
| style="text-align:left" | Impact of the the end of grandfathering period on January 1, {{t|2026|p1abw4-qfy6}}
| style="text-align:right" | <b>-10pts</b> to {{t|215%|p1abw4-ihxj}}
| style="text-align:left" | - Euro {{t|2.4|p1abw4-aw5q}} billion grandfathered debt no longer eligible as capital from January {{t|1|p1abw4-1vtn}}, {{t|2026|p1abw4-zc9z}}
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
Line 844:
 
'''SOLID AND DIVERSIFIED FRANCHISE{{fn ref|1}}'''
* {{t|&#35;1|p1abw4-g31e}} Health & Protection
* {{t|&#35;2|p1abw4-t1su}} {{t|Property & Casualty|p1abw4-8wpp}}
* {{t|&#35;7|p1abw4-z6om}} Savings & Pensions
 
<div style="overflow-x:auto">
Line 870:
 
'''KEY FIGURES{{fn ref|2}}'''
* {{t|>8m|p1abw4-vyyf}} Retail clients{{fn ref|3|2=target of €5bn annually}}
* {{t|1|p1abw4-x9vp}} out of {{t|5|p1abw4-r2tj}} households insured by {{t|AXA|p1abw4-o92o}} in France
* {{t|2.5|p1abw4-dbhe}} contracts per client on average
* {{t|1|p1abw4-twwv}} out of {{t|3|p1abw4-qwel}} SMEs insured by {{t|AXA|p1abw4-alpi}} in France
* {{t|>6m|p1abw4-yfw3}} Employee Benefits beneficiaries
* {{t|1|p1abw4-dsag}} / minute commercial claims covered
* {{t|33,000|p1abw4-d1yd}} people working for {{t|AXA|p1abw4-xjjx}} in France
* {{t|>€10bn|p1abw4-q4y4}} invested in the economy
* {{t|€37€37m|p1abw4-xvfc}}m claims paid per day on average
 
{{pdf page|26|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aaAYJ8FoBIGEg2j6_AXA_Full_Year_Results_2025_Press.pdf}}
Line 884:
 
'''REVENUES'''
* {{t|€31€31bn|p1abw4-ryoe}}bn {{t|+6%|p1abw4-7pby}} vs. {{t|FY24|p1abw4-vwzt}}
* {{t|P&C|p1abw4-76we}} {{t|+7%|}}
* Health & Protection {{t|+4%|p1abw4-2ino}}
* Savings & Pensions {{t|+7%|}}
 
'''KEY TAKEAWAYS'''
* Additional new distributors {{t|+430|p1abw4-8g1q}} nouveaux distributeurs
* Additional contracts{{fn ref|1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}} {{t|+550550k|p1abw4-xv9t}}k net
* Additional clients{{fn ref|1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}} {{t|+250250k|p1abw4-oq7f}}k net
* Growth of individuals savings assets {{t|€+3.33bn|p1abw4-c8vs}}bn
 
<div style="overflow-x:auto">
Line 907:
| style="text-align:right" | {{t|2.1|p1abw4-mxrv}}
| style="text-align:right" | {{t|2.2|p1abw4-8rfo}}
| style="text-align:right" | {{t|+7%|p1abw4-akud}}
|}
</div>
Line 959:
| style="text-align:right" | <b>16%</b>
|-
| style="text-align:left" | CUMULATIVE CASH REMITTANCE BETWEEN 2024 AND {{t|2026|}}{{fn ref|1|2=Cumulative cash remittance between 2024 and 2026}}
| style="text-align:right" | <b>&gt;€21bn</b>
| style="text-align:right" | <b>€14.6bn</b>
Line 966:
 
* Record results, at the top end of the {{t|target range|p1abw4-yg5j}} while enhancing reserve prudence
* Confident to deliver {{t|underlying EPS|p1abw4-de0k}} growth at the upper end of {{t|6%-8%|p1abw4-vkh3}} {{t|target range|p1abw4-twkx}} for {{t|2026|}}
* Laying foundations for the next plan and confident in delivering sustainable earnings growth
 
Line 985:
 
'''S&P Global'''
* {{t|2025|p1abw4-bzki}} percentile: {{t|9797th|p1abw4-pynb}}th{{fn ref|1}} in Dow Jones Best-in-Class Europe & World indices
 
'''MSCI'''
* {{t|2025|}} score: AAA
 
'''CDP'''
* {{t|2025|}} score: B
 
'''MORNINGSTAR SUSTAINALYTICS'''
* {{t|2025|}} ESG Risk Rating: {{t|17.0|p1abw4-lgy1}} – Low risk
 
'''FTSE RUSSELL An LSEG Business'''
* {{t|2025|}} score: {{t|4.3/5|p1abw4-z8e0}} in {{t|FTSE4Good|p1abw4-yy7v}} Index Series
 
{{pdf page|33|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aaAYJ8FoBIGEg2j6_AXA_Full_Year_Results_2025_Press.pdf}}
Line 1,044:
* {{t|1|p1abw4-jul2}}. {{t|FY25|p1abw4-vnif}} {{t|gross written premiums|p1abw4-nxao}} excluding {{t|AXA IM|p1abw4-pjde}}, Holdings, {{t|AXA|p1abw4-nha5}} Assistance, and {{t|AXA|p1abw4-pj1x}} Liabilities Managers.
 
* {{t|1|}}. Change {{t|FY25|}} vs. {{t|FY24|}} at constant fx.
* {{t|2|p1abw4-vjoz}}. Includes {{t|AXA XL|p1abw4-s4u5}} Re premiums of {{t|€2.66bn|p1abw4-g38y}}bn.
 
* {{t|1|}}. Change {{t|FY25|}} vs {{t|FY24|}} at constant fx.
 
* {{t|1|p1abw4-unf7}}. Including both short-term and long-term Employee Benefits {{t|GWP|p1abw4-pvfy}} and {{t|other revenues|p1abw4-ldgp}}.
Line 1,062:
* {{t|1|p1abw4-wodi}}. Shareholders’ equity Group share.
 
* {{t|1|}}. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of {{t|January 1, 2026|p1abw4-fqc0}}, as if the Solvency II revision had come into force on the same date.
 
* {{t|1|p1abw4-0te4}}. Sources: France Assureurs & Argus de l’assurance, {{t|2024|p1abw4-ljg4}} data.